Lancia Reporter – Page 900

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China

SHENZHEN, CHINA – China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 11 December 2025, the New Drug Application (NDA) of Class 1 Innovative Drug Y-3 for Injection (proposed English generic name: Loberamisal for Injection) (“Y-3 for Injection” or the “Product”) has been accepted by National Medical Products Administration…

Kevin Wall Worcester: Local Voices Add Perspective as Civil Liberties Take Center Stage

Worcester, Massachusetts, 11 Dec 2025, ZEX PR WIRE, From school board meetings to courtroom challenges, the conversation around civil liberties in America is evolving. In cities like Worcester, residents such as Kevin Wall are quietly helping keep those conversations alive. Wall isn’t a politician or spokesperson. He’s a longtime Worcester resident who takes an active interest in civil rights…

Vusi Masango Leads South Africa’s AI Quantitative Trading Revolution, Ushering in a New Era of Finance

Posted on March 1, 2025 by Lucas Miller |

Recently, the South African government officially announced the full-scale development and implementation of AI-driven quantitative trading technology, aiming to enhance market security, boost economic vitality, and strengthen the country’s position…

Vusi Masango Leads South Africa’s AI Quantitative Trading Revolution, Ushering in a New Era of Finance

Posted on March 1, 2025 by Lucas Miller |

Featured Posts

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China

Kevin Wall Worcester: Local Voices Add Perspective as Civil Liberties Take Center Stage

Latest Posts

Vusi Masango Leads South Africa’s AI Quantitative Trading Revolution, Ushering in a New Era of Finance

Vusi Masango Leads South Africa’s AI Quantitative Trading Revolution, Ushering in a New Era of Finance